- This event has passed.
Webinar: DILIsym® Applications in Drug Development – Perspectives from 2 Pharma Industry Executives & an Experienced Consultant
April 29 @ 8:00 am - 9:00 am
What do NURTEC™ ODT, TURALIO®, lixivaptan, solithromycin, JYNARQUE®, VEKLURI®, and UBRELVY® have in common? DILIsym®. The drug companies used the software platform for predicting and evaluating liver safety during their development.
In this panel-driven webinar, some of the highest-profile DILIsym applications will be briefly presented, followed by a live Q&A session with:
Dr. Lorenzo Pellegrini, Founder and Chief Operating Officer of Palladio Biosciences
Dr. Paul B. Watkins, Hepatologist and DILI expert who advises drug development programs for most major pharma companies.
Dr. Vlad Coric, Chief Executive Officer of Biohaven Pharmaceuticals
These experts will share their thoughts and opinions, including the future of Quantitative Systems Toxicology in drug development. The webinar will be moderated by Dr. Brett Howell, President of DILIsym Services.